Daylight photodynamic therapy (daylight-PDT) has been used in the treatment of facial and scalp actinic keratoses (AKs) as an alternative of similar efficacy but with greater tolerance than the conventional form of the procedure (c-PDT 
INTRODUCTION
Conventional Photodynamic Therapy (c-PDT) with methyl aminolevulinate cream and red light irradiation three hours after, has been successfully performed for face and scalp actinic keratoses (AKs), with complete response rates that may reach up to 90% within three months, after one or two sessions. A secondary aesthetic effect could also be observed, with the improvement of pigmentation, erythema, roughness, cutaneous paleness, telangiectasia and wrinkles. However, the painful sensibility and intense local cutaneous reactions following the procedure may limit the indication for new sessions.
Daylight Photodynamic Therapy (DLPDT) consist in a recent therapeutic alternative to the conventional method, with similar efficacy in the treatment of Grade I and II facial and scalp AKs. The absence of painful sensibility and intense local cutaneous reactions following the procedure favor the indication of
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METHODS
Twelve patients (eight men and four women) with ages ranging between 38 and 91 years, with at least three Grade I and II facial AKs each and signs of cutaneous aging, underwent two DLPDT sessions, 30 days apart from each other. Half of these patients had previously undergone c-PDT, however, they had not undergone any type of cosmetic or laser treatment in the six months preceding the aforementioned therapy.
The sessions took place in a private clinic in the city of Fortaleza, Ceará, Brazil, on days with bright sunlight or with few clouds in the sky, between 7am and 3pm. On the day of the DLPDT procedure, after the facial cleansing with saline solution with gauze, curettage of the facial AKs was performed, followed by the application of FPS50+ chemical sunscreen lotion (Actinica®, Galderma, France) on the face and other exposed regions. Next, approximately 1g of a thin layer of 16% methyl aminolevulinate cream (Metvix®, Galderma, France) was applied throughout the face, followed by exposure to the open air, under the shade for two hours. Following, the methyl aminolevulinate cream was removed and FPS50+ chemical sunscreen lotion was applied, the patient was released and instructed to maintain a rigorous regime of sunscreen application at home. The procedure was repeated after 30 days.
The number of AKs was evaluated clinically and through digital photographs taken before the DLFDT sessions, on the day of the follow-up visit, and 90 days after the first procedure. A AK lesion was defined as a small keratotic, isolated plaque, with adherent scales, well delineated, located in the area of chronic photo exposure. All patients were also similarly evaluated for overall facial photoaging, diffuse pigmentation, fine wrinkles, facial paleness, roughness, erythema and telangiectasias.
RESULTS
All 12 patients have followed through the end of the treatment. During exposure to open air, there was no report of pain nor were observed intense local cutaneous reactions. The most common side effects were mild pruritus and slight erythema on the areas corresponding to the AK lesions that were clinically visible (Figure 1 ). Regarding the results of the treatment, nine patients were satisfied even before the second session, and none were dissatisfied 90 days after the first session of DLPDT. Satisfaction regarding the clinical improvement of AK lesions and cutaneous rejuvenation were observed in all patients three months after undergoing two sessions of DLPDT, when the authors could observe an improvement in telangiectasias ( Figure  2 ), pigmentation (Figure 3 ), roughness and erythema (Figure 4) , and fine wrinkles ( Figure 5 ).
DISCUSSION
The absence of painful sensitivity and intense local cutaneous reactions in the DLPDT sessions permits that, contrary the conventional form of PDT, the procedure be repeated with greater frequency. Taking into account the chronic and recurring characteristics of the AKs, the possibility of performing a procedure that allows a practically painless treatment of extensive areas of the face and the scalp and still produce secondary aesthetic gain, makes DLPDT a first choice in the treatment of AKs.
The effect regarding aesthetic improvement with c-PDT had already been demonstrated in previous studies. Regarding DLPDT, it was possible to observe that a second session performed after 30 days, aside from having an additional effect in New forms of photodynamic therapy have been performed with microneedling and ablative fractional laser aiming to increase the penetration of the methyl aminolevulinate cream and to improve the efficacy in treating AKs and in rejuvenation. The possibility of repeated sessions of DLPDT may yield a similar effect without the use of laser, LED or any other equipment.
In Brazil, this DLPDT procedure, which can be performed practically throughout the year, allows greater patient compliance by allowing repeated treatments of extensive areas of AKs with minimal discomfort, without disrupting the daily routine of the patient, and with high efficacy and secondary aesthetic gain.
CONCLUSION
Repeated sessions of DLPDT may be performed in such a manner that they are virtually painless and with the added gain of clinical efficacy in patients who have multiple AKs on their face and scalp. Secondary aesthetic gain may also be observed in a more evident manner with at least two sessions of DLPDT, which may be equivalent to the conventional form of PDT, or in combination with ablative methods, however offering the advantage of great tolerance to the procedure. l
